IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 42 filers reported holding IBERE PHARMACEUTICALS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 9,800 | $108,054 | 0.10% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |